Is Addyi indeed proven to boost sexual desire in women? Do adverse reactions to the medicine occur? Does non-brand Flibanserin perform as well as Addyi? What do users think about Addyi, and how do they characterize its effects?
A controversial medication called Addyi claims to boost women’s sexual drive. Many are curious about the new sexual health breakthrough. Female sexuality is finally being studied in a world that studies male sexual disorders. With Addyi making waves in the pharmaceutical sector, it’s important to see whether this pink tablet delivers. Flibanserin, the FDA-approved medicine for decreasing sexual desire in women, has generated many questions, comments, and media queries. In my 20 years as an obstetrician/gynecologist, I’ve never seen such interest in women’s sexual health drugs. Flibanserin is the first FDA-approved sexual function medicine for women. We review Addyi’s possible effects on women’s libido, relationships, and well-being. My patients, coworkers, acquaintances, and neighbors have questions regarding Flibanserin, so I’ll answer them here.
In this article, we will address all of these inquiries by examining clinical trials on Addyi to assess its efficacy, documenting its potential side effects, discussing the effectiveness of the generic version, and providing authentic user reviews of Addyi that are not influenced by sponsorship.
What is Addyi?
Addyi was approved by the U.S. Food and Drug Administration (FDA) in August 2015 and has since been prescribed to women experiencing this condition. Addyi, also known as Flibanserin, is a medication used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women.
The most important fact to note is that Addyi is not intended for use by men and is not a medication used to enhance sexual performance. It is not recommended to improve sexual problems caused by other medical or psychological conditions.
How Does Addyi Work?
Addyi works by influencing certain neurotransmitters in the brain. Specifically, it targets serotonin, dopamine, and norepinephrine levels to address the imbalance contributing to Hypoactive Sexual Desire Disorder (HSDD).
The exact mechanism of action is not entirely understood, but it is believed that Addyi enhances sexual desire while reducing inhibitions. By increasing dopamine and norepinephrine activity and decreasing serotonin activity in specific brain regions, Addyi aims to boost sexual desire in individuals with HSDD.
It’s essential to note that Addyi is not an immediate solution and may take time to show its effects. Additionally, it is intended solely for premenopausal women diagnosed with HSDD. It should not be used for enhancing sexual performance or addressing sexual problems caused by other medical or psychological conditions.
How Effective Is Addyi For HSDD?
Clinical studies have provided valuable insights into Addyi’s (Flibanserin) effectiveness in increasing sex drive in women with Hypoactive Sexual Desire Disorder (HSDD). One notable study published in the Journal of Sexual Medicine in 2015, called the “RECONNECT Study,” examined the impact of Addyi on women with HSDD.
The RECONNECT Study involved over 1,000 premenopausal women diagnosed with HSDD. Half of the participants received Addyi during the study, while the other half received a placebo. The results revealed that women taking Addyi experienced a significant improvement in their sexual desire compared to those who received the placebo.
Specifically, the study showed that women treated with Addyi reported an increase in their desire for sex and a decrease in distress related to their low sexual desire. These findings demonstrated that Addyi could be an effective option for women struggling with HSDD and its associated impact on their sex drive and overall well-being.
While the study provided promising results, it’s important to note that individual responses to Addyi may vary, and not everyone may experience the same level of improvement. Additionally, Addyi may have side effects and is not suitable for everyone, so it should only be used under the guidance of a healthcare professional.
Real reviews Drugs.com
Addyi has been reviewed 65 times on Drugs.com as of July 17, 2023. This website allows prescription medicine users to rate and evaluate their medications. Addyi has a 3.5 out of 10 average rating, the lowest of any prescription drug we’ve reviewed on AzDrug yet.
The most favorable review comes from a user named “Hafabnr,” who claims that the medicine boosted her libido and gives it a score of 10/10:
“I can’t imagine my life without Addyi!” I had forgotten what it was like to have a libido until I started on Addyi. I did not particularly appreciate having sex with my hubby. I only wish I’d discovered this sooner! I’m in my third month and have had no problems. My most significant concern is getting immune to it. “Thank you, Addyi, for giving us women our sex life back!”
The most scathing review is from a user named “Ellie,” who alleges that the medicine caused significant adverse effects and rates it 1/10:
“DO NOT Take THIS MEDICINE! You’ll read some fantastic reviews, but I advise you to read the negative ones since they’re all valid. This medicine has already been taken off the market. Addyi is extremely harmful. I felt different from the start. I felt sleepy all day for the two months I was on it. On top of that, the dizziness and headaches were excruciating. Driving was terrible since I couldn’t see very well half the time. Of course, I’d do everything for my hubby. Finally, I went to my doctor and told her everything. My RESTING heart rate was 140 beats per minute. (I’m 23, weigh 110 pounds, and am quite healthy). She was enraged and astounded that this Addyi firm had not fully disclosed all of the negative effects. She had to give me an injection to relieve my headaches. I had to miss five days of work until the most significant side effects subsided. It took another week for the tiredness to subside. Save yourself the money and the agony.”
Honest, Unsponsored User Review of Addyi
A “dr. coreybabb” user on TikTok posted a review on Addyi and discussed how the medicine affected her.
Just a little video about MY experience with #addyi and #vyleesi, the two FDA-approved medications for #hsdd in premenopausal women. I am neither a woman nor # premenopausal, but I wanted to see how, and if, they worked! original sound – Annemiek
Generic vs. Band
The effectiveness of the generic version of Addyi can vary, and it may not be as straightforward as a simple “yes” or “no” answer. Generic drugs are required by regulatory authorities to demonstrate bioequivalence to the brand-name version, which means they should contain the same active ingredient and produce similar blood levels when taken by individuals.
Studies have shown that generic Flibanserin (the active ingredient in Addyi) can be bioequivalent to the brand-name Addyi. These studies are essential for ensuring that generic versions are safe and effective.
However, despite being bioequivalent, some individuals may still experience differences in their response to the generic version compared to the brand-name drug. Factors such as individual body chemistry, tolerability, and other inactive ingredients in the generic formulation may influence how well it works for a particular person.
For this reason, some individuals may find the generic version of Addyi to be just as effective as the brand-name version. In contrast, others might experience differences in their response or side effects.
Consider using the generic version of Addyi, or else you can go with Addyi. It depends on you; there is no significant difference.
Final Words From AzDrug
Addyi has advantages for improving sexual function in women, although not very well, in our opinion. In the greatest medical trial, the medication boosted gratifying sexual experiences by 0.5 per month above baseline.
The medicine includes adverse effects such as nausea and dizziness, and patients taking Addyi must abstain from alcohol completely to avoid the chance of severe side effects.
At the time of writing, Addyi had the lowest average user rating on Drugs.com of any prescription medicine we’d researched.
The generic form of Addyi is not now available on the market, but it may become accessible in the coming years. Therefore, we recommend that patients check with their doctor at least once a year to see whether generic Flibanserin is available.